Indication
Meibomianitis
Meibomianitis, also termed meibomitis, is an inflammatory disorder affecting the meibomian glands, which are specialized sebaceous glands situated within the tarsal plates of the eyelids. Read more about Meibomianitis
48 drugs 27 manufacturers
Drugs that treat it
Common Meibomianitis therapies.
TOBRAMYCIN
TOBREX (tobramycin)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonMeibomianitis, also termed meibomitis, is an inflammatory disorder affecting the meibomian glands, which are specialized sebaceous glands situated within the tarsal plates of the eyelids.
Typically categorized under posterior blepharitis or inflammatory meibomian gland dysfunction, it commonly affects adults and frequently co-occurs with systemic dermatologic conditions like rosacea or seborrheic dermatitis.
Pathophysiologically, the condition is characterized by terminal duct hyperkeratinization, ductal obstruction, altered lipid (meibum) composition, and bacterial overgrowth.
Clinically, this leads to eyelid margin vascular engorgement, plugged glandular orifices, ocular irritation, and secondary tear film instability, frequently resulting in evaporative dry eye disease.
- nih.gov
Meibomianitis, also termed meibomitis, is an inflammatory disorder affecting the meibomian glands, which are specialized sebaceous glands situated within the tarsal plates of the eyelids Typically categorized under posterior blepharitis or inflammatory meibomian gland dysfunction, it commonly affects adults and frequently co-occurs with systemic dermatologic conditions like rosacea or seborrheic dermatitis Pathophysiologically, the condition is characterized by terminal duct hyperkeratinization,...
- nih.gov
Meibomianitis, also termed meibomitis, is an inflammatory disorder affecting the meibomian glands, which are specialized sebaceous glands situated within the tarsal plates of the eyelids Pathophysiologically, the condition is characterized by terminal duct hyperkeratinization, ductal obstruction, altered lipid (meibum) composition, and bacterial overgrowth
- columbia.edu
Meibomianitis, also termed meibomitis, is an inflammatory disorder affecting the meibomian glands, which are specialized sebaceous glands situated within the tarsal plates of the eyelids Clinically, this leads to eyelid margin vascular engorgement, plugged glandular orifices, ocular irritation, and secondary tear film instability, frequently resulting in evaporative dry eye disease
- aao.org
Typically categorized under posterior blepharitis or inflammatory meibomian gland dysfunction, it commonly affects adults and frequently co-occurs with systemic dermatologic conditions like rosacea or seborrheic dermatitis
- healthline.com
Typically categorized under posterior blepharitis or inflammatory meibomian gland dysfunction, it commonly affects adults and frequently co-occurs with systemic dermatologic conditions like rosacea or seborrheic dermatitis Pathophysiologically, the condition is characterized by terminal duct hyperkeratinization, ductal obstruction, altered lipid (meibum) composition, and bacterial overgrowth
- medlineplus.gov
Pathophysiologically, the condition is characterized by terminal duct hyperkeratinization, ductal obstruction, altered lipid (meibum) composition, and bacterial overgrowth
- sieht.com
Clinically, this leads to eyelid margin vascular engorgement, plugged glandular orifices, ocular irritation, and secondary tear film instability, frequently resulting in evaporative dry eye disease
Personalize your experience
Follow Meibomianitis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.